Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival

Anti-CTLA-4 therapy results in higher CD4+ICOShiT cell frequency and IFN-γ levels in both nonmalignant and malignant prostate tissues

(2009) Hong Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A study of pre-validation

(2008) Holger Höfling et al.   Annals of Applied Statistics

Predicting Clinical Outcome through Molecular Profiling in Stage III Melanoma

(2008) T. John et al.   CLINICAL CANCER RESEARCH

Gene expression profiling for the diagnosis and prognosis of acute myeloid leukaemia

(2008) Ken Mills   Frontiers in Bioscience-Landmark

Predicting Outcomes in Metastatic Melanoma

(2008) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

Enabling personalized cancer medicine through analysis of gene-expression patterns

(2008) Laura J. van 't Veer et al.   NATURE

Molecularly Targeted Therapy in Breast Cancer: The New Generation

(2008) Zeina Nahleh   Recent Patents on Anti-Cancer Drug Discovery